These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 12370108)

  • 1. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R; Keleştimur F; Unlühizarci K; Bayram F; Sahin Y; Tutuş A
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R; Ishai A; Shen-Or Z; Herer P
    Neuro Endocrinol Lett; 2003; 24(3-4):249-54. PubMed ID: 14523365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
    Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Sahin Y; Bayram F
    Eur J Endocrinol; 1999 Jan; 140(1):56-61. PubMed ID: 10037253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT; Senturk LM; Oral E; Colgar U; Ertungealp E
    Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome.
    Kirnap M; Colak R; Eser C; Ozsoy O; Tutus A; Kelestimur F
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
    Ozgen AG; Bayraktar F; Yilmaz C
    Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N; Cetinozman F; Aksoy DY; Elcin G; Yildiz BO
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 17-Hydroxyprogesterone responses to gonadotrophin-releasing hormone agonist buserelin and adrenocorticotrophin in polycystic ovary syndrome: investigation of adrenal and ovarian cytochrome P450c17alpha dysregulation.
    Sahin Y; Keleştimur F
    Hum Reprod; 1997 May; 12(5):910-3. PubMed ID: 9194638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC; Rizos D; Valsamakis G; Deligeoroglou E; Grigoriou O; Chrousos GP; Creatsas G; Mastorakos G
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
    Maas KH; Chuan S; Harrison E; Cook-Andersen H; Duleba AJ; Chang RJ
    Fertil Steril; 2016 Oct; 106(5):1252-1257. PubMed ID: 27473350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E; Kunicki M; Radowicki S
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian-adrenal cross-talk in polycystic ovary syndrome: evidence from wedge resection.
    Wu XK; Zhou SY; Sallinen K; Pöllänen P; Erkkola R
    Eur J Endocrinol; 2000 Sep; 143(3):383-8. PubMed ID: 11022181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of adrenal function in women with oligomenorrhoea and hirsutism (clinical PCOS) from the north-east of England using an adrenal stimulation test.
    Turner EI; Watson MJ; Perry LA; White MC
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):389-97. PubMed ID: 1330379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal dynamic responses to physiologic and pharmacologic adrenocorticotropic hormone stimulation before and after ovarian steroid modulation in women with polycystic ovary syndrome.
    Gonzalez F; Chang L; Horab T; Stanczyk FZ; Crickard K; Lobo RA
    Fertil Steril; 1999 Mar; 71(3):439-44. PubMed ID: 10065779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. During a corticotropin-releasing hormone test in healthy subjects, administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH.
    Kizildere S; Glück T; Zietz B; Schölmerich J; Straub RH
    Eur J Endocrinol; 2003 Jan; 148(1):45-53. PubMed ID: 12534357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
    Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C; Reyna R; Boots LS; Azziz R
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity.
    Laureti S; Candeloro P; Aglietti MC; Giordano R; Arvat E; Ghigo E; Santeusanio F; Falorni A
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):677-83. PubMed ID: 12390344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.